Courtney Arianne Washington, DO Introduction Losing weight is one thing, but losing fat while preserving muscle is the real challenge
Case reports and case series have documented instances of severe, persistent gastroparesis temporally associated with GLP-1 initiation, with some patients requiring hospitalization for refractory nausea and vomiting
While the flat-rate pricing of compounding pharmacies looks attractive if you lack insurance coverage, you must weigh those savings against many safety concerns
If you develop a firm raised area at a previous injection site, avoid that spot until it resolves and mention it to your prescriber at the next appointment
"That person may be able to be more active after losing the weight, perhaps they're sleeping better and having fewer sleep apnea events (which have been linked as a risk factor for type two diabetes)
Diarrhea occurs in approximately 30% of patients taking semaglutide 2.4 mg (Wegovy) and 19-23% of patients taking tirzepatide (Zepbound) according to FDA prescribing information